Sarah Sammons, MD, associate director of the metastatic breast cancer program at Dana-Farber Cancer Institute, and Virginia Kaklamani, MD, leader of the breast medical oncology program at Mays Cancer Center at UT Health San Antonio, reflect on the highest impact science of 2023 in breast cancer research.